XML 47 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
NOTE 26 – SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
NOTE 26 – SUBSEQUENT EVENTS

NOTE 26 – SUBSEQUENT EVENTS

Salisbury has evaluated subsequent events for potential recognition and/or disclosure through the date these consolidated financial statements were issued. In January 2022, Salisbury completed the sale of the building housing its retail branch in Poughkeepsie, New York. The branch was relocated to leased space nearby and Salisbury recorded a pre-tax loss of approximately $144 thousand on this sale in its consolidated financial statements at December 31, 2021.

The Board of Directors of Salisbury approved a $0.01 increase in the quarterly dividend to $0.32 per common share at their January 26, 2022 meeting. The dividend was paid on February 25, 2022 to shareholders of record as of February 11, 2022. 

On February 28, 2022, the Compensation Committee of the Board of Directors approved grants of performance-based restricted stock units (“RSUs”) to named executive officers (“NEOs”) and other key employees under the Company’s 2017 Long Term Incentive Plan. The Compensation Committee granted a total of 6,950 RSUs, including 3,500 RSUs to NEOs. Richard J. Cantele, Jr., President and Chief Executive Officer received 1,500 target RSUs; John M. Davies, President of NY Region and Chief Lending Officer received 1,000 target RSUs; and Peter Albero, Executive Vice President and Chief Financial Officer received 1,000 target RSUs. The maximum number of shares deliverable upon vesting of RSUs assuming 150% of the TBV growth target is met or exceeded, will be 10,425.

On February 28, 2022, Salisbury granted a total of 14,350 shares of restricted stock to certain employees pursuant to its 2017 Long Term Incentive Plan. The fair value of the stock granted was approximately $813 thousand.

On March 1, 2022, Salisbury issued a press release that the Board has approved and will recommend to shareholders an amendment to Salisbury’s Certificate of Incorporation to increase Salisbury’s authorized shares of Common Stock from 5,000,000 to 10,000,000 shares, subject to shareholder approval (the “Certificate of Amendment Proposal”). Additionally, the Board approved, subject to shareholder approval of the Certificate of Amendment Proposal, a two for one forward split of the shares of the Company’s Common Stock as a means of enhancing the liquidity and marketability of the Company’s securities in the best interests of shareholders.